7
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Prospects for the Use of Induced Pluripotent Stem Cells in Animal Conservation and Environmental Protection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Summary

          Stem cells are unique cell populations able to copy themselves exactly as well as specialize into new cell types. Stem cells isolated from early stages of embryo development are pluripotent, i.e., can be differentiated into multiple different cell types. In addition, scientists have found a way of reverting specialized cells from an adult into an embryonic‐like state. These cells, that are as effective as cells isolated from early embryos, are termed induced pluripotent stem cells (iPSCs). The potency of iPSC technology is recently being employed by researchers aimed at helping wildlife and environmental conservation efforts. Ambitious attempts using iPSCs are being made to preserve endangered animals as well as reanimate extinct species, merging science fiction with reality. Other research to sustain natural resources and promote animal welfare are exploring iPSCs for laboratory grown animal products without harm to animals offering unorthodox options for creating meat, leather, and fur. There is great potential in iPSC technology and what can be achieved in consumerism, animal welfare, and environmental protection and conservation. Here, we discuss current research in the field of iPSCs and how these research groups are attempting to achieve their goals. S tem C ells T ranslational M edicine 2019;8:7–13

          Related collections

          Most cited references34

          • Record: found
          • Abstract: found
          • Article: not found

          Reconstitution of the mouse germ cell specification pathway in culture by pluripotent stem cells.

          The generation of properly functioning gametes in vitro requires reconstitution of the multistepped pathway of germ cell development. We demonstrate here the generation of primordial germ cell-like cells (PGCLCs) in mice with robust capacity for spermatogenesis. PGCLCs were generated from embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) through epiblast-like cells (EpiLCs), a cellular state highly similar to pregastrulating epiblasts but distinct from epiblast stem cells (EpiSCs). Reflecting epiblast development, EpiLC induction from ESCs/iPSCs is a progressive process, and EpiLCs highly competent for the PGC fate are a transient entity. The global transcription profiles, epigenetic reprogramming, and cellular dynamics during PGCLC induction from EpiLCs meticulously capture those associated with PGC specification from the epiblasts. Furthermore, we identify Integrin-β3 and SSEA1 as markers that allow the isolation of PGCLCs with spermatogenic capacity from tumorigenic undifferentiated cells. Our findings provide a paradigm for the first step of in vitro gametogenesis. Copyright © 2011 Elsevier Inc. All rights reserved.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Offspring from oocytes derived from in vitro primordial germ cell-like cells in mice.

            Reconstitution of female germ cell development in vitro is a key challenge in reproductive biology and medicine. We show here that female (XX) embryonic stem cells and induced pluripotent stem cells in mice are induced into primordial germ cell-like cells (PGCLCs), which, when aggregated with female gonadal somatic cells as reconstituted ovaries, undergo X-reactivation, imprint erasure, and cyst formation, and exhibit meiotic potential. Upon transplantation under mouse ovarian bursa, PGCLCs in the reconstituted ovaries mature into germinal vesicle-stage oocytes, which then contribute to fertile offspring after in vitro maturation and fertilization. Our culture system serves as a robust foundation for the investigation of key properties of female germ cells, including the acquisition of totipotency, and for the reconstitution of whole female germ cell development in vitro.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Reconstitution in vitro of the entire cycle of the mouse female germ line.

              The female germ line undergoes a unique sequence of differentiation processes that confers totipotency to the egg. The reconstitution of these events in vitro using pluripotent stem cells is a key achievement in reproductive biology and regenerative medicine. Here we report successful reconstitution in vitro of the entire process of oogenesis from mouse pluripotent stem cells. Fully potent mature oocytes were generated in culture from embryonic stem cells and from induced pluripotent stem cells derived from both embryonic fibroblasts and adult tail tip fibroblasts. Moreover, pluripotent stem cell lines were re-derived from the eggs that were generated in vitro, thereby reconstituting the full female germline cycle in a dish. This culture system will provide a platform for elucidating the molecular mechanisms underlying totipotency and the production of oocytes of other mammalian species in culture.
                Bookmark

                Author and article information

                Contributors
                morgan@vitrolabsinc.com
                dusko.ilic@kcl.ac.uk
                Journal
                Stem Cells Transl Med
                Stem Cells Transl Med
                10.1002/(ISSN)2157-6580
                SCT3
                Stem Cells Translational Medicine
                John Wiley & Sons, Inc. (Hoboken, USA )
                2157-6564
                2157-6580
                24 September 2018
                January 2019
                : 8
                : 1 ( doiID: 10.1002/sct3.2019.8.issue-1 )
                : 7-13
                Affiliations
                [ 1 ] VitroLabs Inc. South San Francisco California USA
                [ 2 ] Department of Women and Children's Health, Faculty of Science and Medicine King's College London, School of Life Course Sciences London United Kingdom
                Author notes
                [*] [* ]Correspondence: Morgan M. Stanton, Ph.D., VitroLabs Inc., 6000 Shoreline Ct. Ste 204, South San Francisco, CA 94080, USA. Tel: +1 415 853 8653; e‐mail: morgan@ 123456vitrolabsinc.com or Dusko Ilic, M.D., Ph.D., Assisted Conception Unit, 11th Fl., Tower Wing, Guy's Hospital, London, SE1 9RT, UK. Tel: +44 (0) 20 7188 0571; e‐mail: dusko.ilic@ 123456kcl.ac.uk
                Author information
                https://orcid.org/0000-0003-1647-0026
                Article
                SCT312401
                10.1002/sctm.18-0047
                6312526
                30251393
                2d089df4-b233-4748-8dd4-3ab1d797bf25
                © 2018 The Authors. stem cells translational medicine published by Wiley Periodicals, Inc. on behalf of AlphaMed Press

                This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.

                History
                : 05 March 2018
                : 23 August 2018
                Page count
                Figures: 1, Tables: 2, Pages: 7, Words: 5371
                Categories
                Perspectives
                Perspectives
                Custom metadata
                2.0
                sct312401
                January 2019
                Converter:WILEY_ML3GV2_TO_NLMPMC version:version=5.5.4 mode:remove_FC converted:31.12.2018

                Comments

                Comment on this article